Skip to main content
Clinical Trials/KCT0000155
KCT0000155
Recruiting
未知

Comparison catheter ablation versus permanent pacemaker implantation in patients with tachycardia-bradycardia syndrome: prospective, randomized trial

Asan Medical Center0 sites88 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Asan Medical Center
Enrollment
88
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Documented prolonged sinus pauses on termination of AF ranging from 3 to 9 seconds
  • 2\. Symptoms of syncope or presyncope
  • 3\. Informed consent

Exclusion Criteria

  • 1\. Left ventricular ejection fraction \< 40%
  • 2\. prior history of ablation of atrial fibrillation
  • 3\. thrombi in Left atrium or Left atrial appendage
  • 4\. New York Heart Association class III or IV
  • 5\. prior acute myocardial infarction or coronary artery bypass grafting within 6 months
  • 6\. prior percutaneous coronary intervention within 1 year
  • 7\. Severe valvular disease
  • 8\. Life expectancy of less than one year
  • 9\. Contraindication of anticoagulants
  • 10\. Pregnant women or women planning pregnancy(The urine hCG test is usually performed in women of reproductive age)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Catheter Ablation compared with Pharmacological Therapy for Atrial Fibrillation – the CAPTAF trial - captafTo study the effect of catheter ablation (using CE marked products) on the quality of life an in patients with atrial fibrillation depsite treatment with conevntional antiarrhythmic medical therapy.atrial fibrillation is thus the disease to be investigatedMedDRA version: 9.1Level: LLTClassification code 10066664Term: Recurrent symptomatic atrial fibrillation
EUCTR2008-001384-11-SE250
Active, not recruiting
Phase 1
Elimination of ventricular premature beats and ventricular tachycardia with catheter ablation versus optimal anti-arrhythmic drug treatmentPremature ventricular beats, ventricular ectopy, ventricle tachycardiaTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2018-001518-13-NLMaatschap Cardiologie Zwolle180
Completed
Not Applicable
A multicentre randomized control study of atrial fibrillation in heart failure (CAMERA-MRI)Atrial FibrillationHeart FailureCardiovascular - Other cardiovascular diseases
ACTRN12613000880741Baker IDI Heart & Diabetes Institute66
Active, not recruiting
Not Applicable
A Study of the Outcome of Catheter Ablation for Atrial Fibrillation Complicated by Hypertrophic CardiomyopathyHypertrophioc cardiomyopathyHypertrophic cardiomyopathy, atrial fibrillationD002312
JPRN-jRCT1020230057Kinjo Takahiko60
Active, not recruiting
Not Applicable
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialAtrial fibrillationTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-002532-12-CZMayo Clinic3,000